Kymera Therapeutics, Inc. (KYMR)

88.56 +0.49 (+0.56%) USD  |  NASDAQ  |  Apr 22, 12:54
More

Kymera Therapeutics Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade